INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE

被引:963
作者
CARLSSON, M
CARLSSON, A
机构
[1] Department of Pharmacology, University of Göteborg, S-400 33 Göteborg
关键词
D O I
10.1016/0166-2236(90)90108-M
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent animal experiments suggest that dopamine plays a less crucial role than formerly supposed in the regulation of psychomotor functions. This is illustrated by the finding that even in the almost complete absence of brain dopamine, a pronounced behavioural activation is produced in mice following suppression of glutamatergic neurotransmission. This paper discusses the possibility that a deficient activity within the corticostriatal glutamatergic/aspartergic pathway may be an important pathophysiological component in schizophrenia, and that glutamatergic agonists may be beneficial in the treatment of this disease. In addition, it is suggested that glutamatergic antagonists may be valuable supplements in the treatment of Parkinson's disease. © 1990.
引用
收藏
页码:272 / 276
页数:5
相关论文
共 61 条